Intervention for Health Care Providers

Phase-Based Progress Estimates
Jewish General Hospital, Montreal, Canada
Health Care Providers+2 More
Direct participation of the family member in the daily rounds - Other
All Sexes
What conditions do you have?

Study Summary

This is a single-center, unblinded, pragmatic randomized controlled trial comparing family participation in cardiac ICU team rounds with usual care. We will recruit 112 family members. The primary outcome will be family member care satisfaction. Secondary outcomes will include family mental health and care engagement. The beliefs, attitudes, and knowledge of healthcare providers, including medical trainees, about family participation in rounds will be evaluated prior to and following the intervention.

Eligible Conditions

  • Family Members
  • Health Care Providers
  • Patient Engagement

Treatment Effectiveness

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Through study completion, up to 4 weeks

Week 4
Change in Attitudes and Knowledge of Healthcare Providers as measured by the QFIFE survey
Week 2
Family Care Satisfaction as Measured by the FS-ICU Survey.
Family Engagement in Care as Measured by the FAMily Engagement (FAME) Survey
Family Mental Health as Measured by the Hospital Anxiety and Depression Scale (HADS) Survey

Trial Safety

Trial Design

2 Treatment Groups

Usual care
1 of 2
1 of 2
Active Control
Experimental Treatment

220 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention · No Placebo Group · N/A

Experimental Group · 1 Intervention: Direct participation of the family member in the daily rounds · Intervention Types: Other
Usual careNoIntervention Group · 1 Intervention: Usual care · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, up to 4 weeks
Closest Location: Jewish General Hospital · Montreal, Canada
Photo of montreal  1Photo of montreal  2Photo of montreal  3
2006First Recorded Clinical Trial
1 TrialsResearching Health Care Providers
245 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.